rs2271189
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001982.4(ERBB3):c.3348G>A(p.Arg1116Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.373 in 1,613,462 control chromosomes in the GnomAD database, including 116,569 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.31 ( 8334 hom., cov: 30)
Exomes 𝑓: 0.38 ( 108235 hom. )
Consequence
ERBB3
NM_001982.4 synonymous
NM_001982.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.554
Genes affected
ERBB3 (HGNC:3431): (erb-b2 receptor tyrosine kinase 3) This gene encodes a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. This membrane-bound protein has a neuregulin binding domain but not an active kinase domain. It therefore can bind this ligand but not convey the signal into the cell through protein phosphorylation. However, it does form heterodimers with other EGF receptor family members which do have kinase activity. Heterodimerization leads to the activation of pathways which lead to cell proliferation or differentiation. Amplification of this gene and/or overexpression of its protein have been reported in numerous cancers, including prostate, bladder, and breast tumors. Alternate transcriptional splice variants encoding different isoforms have been characterized. One isoform lacks the intermembrane region and is secreted outside the cell. This form acts to modulate the activity of the membrane-bound form. Additional splice variants have also been reported, but they have not been thoroughly characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 12-56101207-G-A is Benign according to our data. Variant chr12-56101207-G-A is described in ClinVar as [Benign]. Clinvar id is 1248586.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-56101207-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.554 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.396 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERBB3 | NM_001982.4 | c.3348G>A | p.Arg1116Arg | synonymous_variant | 27/28 | ENST00000267101.8 | NP_001973.2 | |
ERBB3 | XM_047428500.1 | c.3171G>A | p.Arg1057Arg | synonymous_variant | 27/28 | XP_047284456.1 | ||
ERBB3 | XM_047428501.1 | c.3171G>A | p.Arg1057Arg | synonymous_variant | 27/28 | XP_047284457.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERBB3 | ENST00000267101.8 | c.3348G>A | p.Arg1116Arg | synonymous_variant | 27/28 | 1 | NM_001982.4 | ENSP00000267101.4 |
Frequencies
GnomAD3 genomes AF: 0.308 AC: 46725AN: 151578Hom.: 8330 Cov.: 30
GnomAD3 genomes
AF:
AC:
46725
AN:
151578
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.347 AC: 87056AN: 251170Hom.: 15827 AF XY: 0.347 AC XY: 47112AN XY: 135776
GnomAD3 exomes
AF:
AC:
87056
AN:
251170
Hom.:
AF XY:
AC XY:
47112
AN XY:
135776
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.380 AC: 555279AN: 1461766Hom.: 108235 Cov.: 57 AF XY: 0.377 AC XY: 274491AN XY: 727198
GnomAD4 exome
AF:
AC:
555279
AN:
1461766
Hom.:
Cov.:
57
AF XY:
AC XY:
274491
AN XY:
727198
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.308 AC: 46746AN: 151696Hom.: 8334 Cov.: 30 AF XY: 0.306 AC XY: 22654AN XY: 74134
GnomAD4 genome
AF:
AC:
46746
AN:
151696
Hom.:
Cov.:
30
AF XY:
AC XY:
22654
AN XY:
74134
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
954
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 05, 2019 | - - |
Lethal congenital contracture syndrome 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Visceral neuropathy, familial Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at